Home » Topics » Conferences

Conferences
RSS

VPA-985 characterized as potent, selective, orally active V2 antagonist

Nov. 13, 1998

BG-9719 has potent natriuretic effects in patients with CHF

Nov. 13, 1998

McMaster University researchers target potential gene therapies for arthritis

Nov. 13, 1998

Bristol-Myers Squibb initiates phase III HBV clinical trials; phase II data reported

Nov. 13, 1998

SB-205553 used to investigate role of 5-HT2C receptor antagonists in PD therapy

Nov. 13, 1998

Leflunomide reduces symptoms of rheumatoid arthritis, slows disease progression in new studies

Nov. 13, 1998

First clinical results reported for novel gene therapy in coronary artery disease

Nov. 12, 1998

SPBN: a free radical scavenger with potential in pediatric head trauma

Nov. 12, 1998

NK2 antagonist from Zeneca blocks increased pulmonary resistance in guinea pigs

Nov. 12, 1998

New mechanism of action described for immunomodulating agent OM-89

Nov. 12, 1998

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...